Extractas Bioscience Overview

  • Founded
  • 1975

Founded
  • Status
  • Private

  • Employees
  • 61

Employees
  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Extractas Bioscience General Information

Description

Provider of agricultural research and development, extraction and purification services for high-value plant-derived products, with a particular focus on alkaloid raw materials used in the production of active pharmaceutical ingredients. The company specializes in research, manufacturing and export of botanical extracts and purified products and is a fully-integrated manufacturer of controlled substances providing medicinal opiates from patented poppy varieties grown on the farms of Tasmania.

Contact Information

Formerly Known As
Tasmanian Alkaloids
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • P.O. Box 130
  • Westbury, Tasmania 7303
  • Australia
+61 (03) 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Extractas Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Extractas Bioscience‘s full profile, request access.

Request a free trial

Extractas Bioscience Patents

Extractas Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3758728-A4 A plant of papaver somniferum with an altered alkaloid profile Pending 02-Mar-2018 00000000 0
EP-3758728-A1 A plant of papaver somniferum with an altered alkaloid profile Pending 02-Mar-2018 00000000
US-20210000061-A1 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018 00000000
AU-2018900692-A0 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018
AU-2019226633-A1 A plant of papaver somniferum with an altered alkaloid profile Pending 02-Mar-2018 A01H6/64
To view Extractas Bioscience’s complete patent history, request access »

Extractas Bioscience Executive Team (3)

Name Title Board Seat Contact Info
Ross Murdoch Ph.D Chief Executive Officer
Ian Jones Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Extractas Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Extractas Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Extractas Bioscience‘s full profile, request access.

Request a free trial